VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 410.6 EUR -0.07%

Market Cap: €42.6B

V	Vertex Pharmaceuticals Inc XHAM:VX1	US
	St James's Place PLC OTC:STJPF	UK
	Liberty Latin America Ltd F:1LLC	US
C	Corning Inc BMV:GLW	US
T	TotalEnergies SE DUS:TOTB	FR
B	Bank of America Corp XMUN:NCB	US
	BHP Group Ltd ASX:BHP	AU
	Daito Trust Construction Co Ltd OTC:DIFTY	JP
T	TAG Immobilien AG F:TEG	DE
	Lumentum Holdings Inc NASDAQ:LITE	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

41% > 30%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.